Related Experiment Video

Updated: Aug 6, 2026

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

Octreotide therapy for chylothorax in infants and children: A brief review

Radley D Helin1, Sheila Therese V Angeles, Rama Bhat

  • 1Department of Pediatrics, University of Illinois Medical Center at Chicago, Chicago, IL, USA.

Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
|August 1, 2006
PubMed

Insights

Octreotide is a useful treatment for chylothorax in infants and children. Higher doses initiated early may be more effective than gradual increases, though optimal treatment varies.

Area of Science:

  • Pediatric Pharmacology
  • Neonatal Medicine
  • Thoracic Surgery

Background:

  • Chylothorax, characterized by lymphatic fluid in the pleural space, presents a significant challenge in pediatric and neonatal care.
  • Octreotide, a somatostatin analog, has emerged as a potential therapeutic agent for managing this condition.

Purpose of the Study:

  • To review the physiology and pharmacology of octreotide relevant to chylothorax treatment in pediatric populations.
  • To synthesize the published data on octreotide dosing and efficacy for chylothorax in infants and children.

Main Methods:

  • A systematic literature review was conducted.
  • Databases searched included PubMed, with additional data from article citations, textbooks, and personal files.

Main Results:

  • Octreotide has demonstrated success as an adjunct therapy in both neonatal and pediatric cases of chylothorax.
  • Published literature shows varied approaches to octreotide administration, including dose, duration, and discontinuation strategies.

Conclusions:

  • While effective, there is no established consensus on the optimal octreotide regimen for chylothorax.
  • The study suggests considering higher initial doses (80-100 microg/kg/day) and early intervention for potentially better outcomes.
  • Individual patient variability necessitates tailored treatment durations.
Abstract

Related Concept Videos

Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...